Stelexis Biosciences
Clinical trials sponsored by Stelexis Biosciences, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug STLX-2012 tested in healthy people for first time Results expected Feb 2027 (estimated)
- New hope for hard-to-treat leukemia? early trial tests eganelisib alone and with chemo. Results expected Jul 2027 (estimated)